Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

What next? Choosing second-line therapy in progressive renal cell carcinoma.

Bourlon MT, Kessler ER. What next? Choosing second-line therapy in progressive renal cell carcinoma. Oncology (Williston Park). 2014 Sep; 28(9):794-6.

View in: PubMed

collapse authors with profiles


Copyright © 2023 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)